Skip to main content
Glama

pcac

GET https://ticks.bnm.farm/pcac — $0.05 USDC on Base to 0xf59621FC406D266e18f314Ae18eF0a33b8401004. FDA PCAC 503A briefing-memo evaluation text GET ?id= is one official text ($0.02). Newest chunk on a plain GET ($0.05); older chunk if they ask (?before, $0.05). Unpaid returns HTTP 402. After a valid X-PAYMENT, the same URL returns JSON. Not a new SKU.

Input Schema

TableJSON Schema
NameRequiredDescriptionDefault
idNoOfficial catalog id. That one official text, $0.02. Same door, not a new SKU.
pageNo1-based page. Page 1 is the newest chunk. Ignored when before is set.
beforeNoOfficial catalog id or YYYY-MM-DD. Next older chunk on the same URL, another $0.05. Omit for the newest chunk.
x_paymentNoOptional x402 X-PAYMENT value forwarded to the paid GET as the X-PAYMENT header.

TDQS

A3.9/5.0
Behavior4/5

Does the description disclose side effects, auth requirements, rate limits, or destructive behavior?

With no annotations, the description carries the full burden of behavioral disclosure. It openly states the payment amount, recipient address, unpaid HTTP 402 response, and the JSON return after a valid X-PAYMENT, which covers the most important behavioral surprises for this paid endpoint. It does not mention rate limits or invalid-payment handling, but the core behavior is clearly exposed.

Agents need to know what a tool does to the world before calling it. Descriptions should go beyond structured annotations to explain consequences.

Conciseness4/5

Is the description appropriately sized, front-loaded, and free of redundancy?

The description is compact and front-loaded with the endpoint, price, and payment target. It packs several useful behaviors into short sentences, though it is slightly run-on and repeats 'not a new SKU' which also appears in the id parameter description.

Shorter descriptions cost fewer tokens and are easier for agents to parse. Every sentence should earn its place.

Completeness4/5

Given the tool's complexity, does the description cover enough for an agent to succeed on first attempt?

For a paid, no-annotations tool with no output schema, the description covers the essential calling contract: endpoint, pricing, chunk selection, id selection, unpai behavior, and X-PAYMENT requirement. The main gap is that it leaves the page parameter entirely to the schema and gives no return-shape detail beyond 'JSON', but the overall calling contract is clear enough.

Complex tools with many parameters or behaviors need more documentation. Simple tools need less. This dimension scales expectations accordingly.

Parameters3/5

Does the description clarify parameter syntax, constraints, interactions, or defaults beyond what the schema provides?

Schema coverage is 100%, so the schema already documents all four parameters. The description adds pricing context for the default/newest chunk and repeats the id cost, but it does not substantially augment the schema's parameter descriptions (page is still only explained in the schema). Baseline 3 is appropriate.

Input schemas describe structure but not intent. Descriptions should explain non-obvious parameter relationships and valid value ranges.

Purpose4/5

Does the description clearly state what the tool does and how it differs from similar tools?

The description identifies the exact HTTP verb and endpoint and names the resource ('FDA PCAC 503A briefing-memo evaluation text'), so an agent can tell what content this tool serves. It also distinguishes the retrieval modes (official text by id, newest chunk, older chunk), though it does not explicitly contrast with sibling tools.

Agents choose between tools based on descriptions. A clear purpose with a specific verb and resource helps agents select the right tool.

Usage Guidelines4/5

Does the description explain when to use this tool, when not to, or what alternatives exist?

The description gives concrete selection guidance: use a plain GET for the newest chunk, ?before for an older chunk, and ?id= for one official text. It also states the unpaid/paid behavior (HTTP 402 vs. JSON after a valid X-PAYMENT), but it does not explicitly describe when pcac should be preferred over sibling tools.

Agents often have multiple tools that could apply. Explicit usage guidance like "use X instead of Y when Z" prevents misuse.

Try in Browser

Glama MCP Gateway

Add one secure layer between your agents and this server.

TDQS

B3.4/5.0
Disambiguation3/5

Most tools map cleanly to distinct regulatory document collections (FDA, EPA, FDIC, etc.), so the majority are unambiguous. However, 'search' and 'firm-check' both offer free search with overlapping scope, and 'get-one' vs 'get-page' are easily confused payment operations. Similar prefixed names like mariners, mariners-d7/d8/d11 and gmp/gmp-md add further boundary fuzziness.

Naming Consistency3/5

The bulk of tools follow a consistent lowercase-hyphenated source-slug convention (aaib-reports, cder-reviews, cfpb-orders), which is predictable. But utility tools break the pattern with imperative/descriptive names (search, firm-check, get-one, get-page), and 'ticks' is a bare noun that doesn't fit either style. The mixed conventions are readable but not uniform.

Tool Count2/5

At 46 tools, this is a heavy surface that will be unwieldy for an agent to navigate and select from. Each tool does represent a distinct data product, but the sheer volume exceeds what earns its place in a coherent MCP tool set. A door-based catalog design might work better with a smaller number of parameterized tools.

Completeness4/5

The core workflow is well covered: per-door search, cross-door search, single-document retrieval via ?id=, paginated page retrieval, and payment handling are all present. Minor gaps exist, such as no tool to enumerate all available doors/catalogs or inspect schemas, and firm-check returns only citations rather than bodies. Overall it's a complete access lifecycle for the data-shop domain.